All GLP-1 RAs induce a significant reduction in energy intake, which is the primary driver of their weight loss efficacy
Intriguingly, this supports previous suggestions that the JAK2 pseudokinase interaction and inhibition of the KD is different between the receptor bound JAK2 and the receptor free JAK2 (90)
Several studies suggest that adequate levels of 25(OH)D are associated with better glucose control, particularly in individuals with insulin resistance or T2DM ( In terms of lipid modification, we found no association between 25(OH)D categorization and lipid reduction
Moving forward, it is important for clinicians to be aware of the possibility of known or novel injection-site reactions in response to GLP-1RAs
Individuals with Obesity Those with a BMI over 30, or over 27 with health issues (like high blood pressure), may qualify for GLP-1 treatment for weight loss
Semaglutide Packages: Comprehensive support for weight management with options for those with existing prescriptions, as well as telehealth consultations for those needing a prescription
